Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer - Drug Trials For Money - Paid Clinical Trials

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
Condition:   Pancreatic Cancer Stage IV
Interventions:   Drug: CBP501 (16);   Drug: CBP501 (25);   Drug: Cisplatin;   Drug: Nivolumab
Sponsor:   CanBas Co. Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022 / by / in
Comments